| |
|
|
|
EyePoint Pharmaceuticals Inc.  
|
|
0.745 -0.005 (-0.01%) |
07-13 13:47 |
|
Open: |
0.75 |
Pre close: |
0.75 |
Target:
|
1.16
|
|
High: |
0.7697 |
Low: |
0.728 |
Resistance:
|
0.99
1.20
|
|
Volume: |
249,689 |
Market Cap: |
93M |
Support:
|
0.66
0.55
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.73
 |
MACD |
MACD(12,26):
|
-0.04 |
|
MA(20): |
0.78  |
Signal(12,26,9): |
-0.03 |
|
MA(100): |
0.94 |
Stochastic Oscillator |
%K(14,3):
|
13.95 |
|
MA(250): |
1.39 |
%D(3): |
7.41 |
|
Average Volume(K) |
3-Month: |
88253
|
52-Week |
High:
|
2.69 |
|
10-Days: |
48515 |
Low: |
0.66 |
|
RSI |
RSI(14):
|
41.39 |
Change(%): |
-50.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.464 |
Return on Equity (ttm) |
-279.1 |
Shares Out. (M) |
124.74 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-34.4 |
Shares Float (M) |
76.40 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.82 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
272.2 |
% Held by Institutions |
53.74 |
|
Forward EPS |
-0.540 |
Gross Profit (p.s.) |
0.019 |
Shares Short (K) |
4500 |
|
Book Value (p.s.) |
0.130 |
EBITDA (p.s.) |
-0.337 |
P/E |
-1.57 |
|
Sales Per Share |
0.207 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.60 |
|
Profit Margin |
-196.30 |
Operating Cash Flow
(M) |
-59.71 |
P/S |
3.51 |
|
Operating Margin |
-172.80 |
Levered Free Cash Flow
(M) |
-57.48 |
P/CF |
-1.52 |
|
|
|
|
|
|
